The Longest Standing & Pre-Eminent European ADC Forum
16th World ADC London | 800+ Industry Attendees | 240+ Companies | 110+ Global Speakers

With traditional ADCs now fulfilling their potential to reshape oncology care, the bioconjugate community is doubling down on differentiation to ensure the next generation delivers meaningful patient impact.

Returning as the longest-standing and definitive ADC forum in Europe, 16th World ADC London 2026 is the must-attend event for anyone working in or looking to learn about bioconjugates. Leverage cutting-edge R&D, strategic insights, and unparalleled networking to advance ADC innovation and maximise therapeutic potential.

Agenda Highlights:
The 2026 programme features 5 end-to-end content streams covering discovery, preclinical translation, clinical lessons, process & analytical development, and manufacturing & supply chain. Sessions are infused with trailblazing approaches to overcome patient resistance and accelerate ADCs into earlier-line oncology treatments. Topics include:

• Novel cytotoxic and non-cytotoxic payloads
• Dual payload ADCs
• Bispecific and biparatopic ADCs
• Non-antibody and fragment conjugates

Global Speaker Faculty:
Hear from 110+ experts across Europe, North America, and Asia sharing actionable insights to advance your pipeline, including:

• Elaine Hurt, Executive Director & Head, Tumour Targeted Delivery Bioscience, Oncology R&D, AstraZeneca
• Guillaume Bergthold, Executive Director, Clinical Development, Daiichi Sankyo
• Alan Russell, VP Research & Head, R&D Technology & Innovation, Amgen
• Andras Strassz, Chief Medical Officer, Heidelberg Pharma
• Marija Vrljic, VP, Antibody Technologies, ALX Oncology (New Company)
• Jonathan Davis, Director, ADC Discovery, Helix Biopharma (New Company)
• Zhenwei Miao, Founder & Chairman, Adcoris Biopharma (New Company)

Who Will Attend:
Join 800+ senior ADC decision-makers from biopharma, clinical research, service providers, investors, and regulators, uniting to shape the future of ADC development.

Explore the full agenda for a complete breakdown of all sessions, speakers, and networking opportunities.